$GMED · GLOBUS MEDICAL INC SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for GLOBUS MEDICAL INC ($GMED) from November 5, 2026 through November 6, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$GMED 10-Q — GLOBUS MEDICAL INC
Globus delivered a strong profit beat on cost discipline even as revenue shrank, testing whether margin gains can sustain the stock without top-line growth.
$GMED 8-K — GLOBUS MEDICAL INC
A guidance cut paired with a $500M buyback increase signals management confidence in cash generation despite slowing top-line growth.